Skip to main content

Table 3 Likelihood of improvement versus quantification.

From: Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome

 

SEE 1

SEE 2

SEE 3

SEE 4

SEE 5

2SD

1

0,7

1,2

2,0

2,5

3SD

1

1,6

3,8

3,8

5,2

4SD

1

1,3

1,5

3,4

4,5

5SD

1

1,5

3,1

4,3

6,1

6SD

1

2,9

4,7

5,2

14,8

7SD

1

2,0

4,4

3,9

10,8

8SD

1

2,1

4,1

3,2

9,6

FWHM

1

2,4

3,5

4,7

5,5

  1. SEE = segmental extent of hyperenhancement. Numbers represent odds ratios of likelihood of improvement of SEE 2–5 versus SEE 1, which is set at 1.
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us